Chemoinformaics analysis of geranyl vinyl ether
| Molecular Weight | 180.291 | nRot | 6 |
| Heavy Atom Molecular Weight | 160.131 | nRig | 3 |
| Exact Molecular Weight | 180.151 | nRing | 0 |
| Solubility: LogS | -4.243 | nHRing | 0 |
| Solubility: LogP | 5.029 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 34.1779 |
| nHD | 0 | BPOL | 21.8001 |
| QED | 0.343 |
| Synth | 3.07 |
| Natural Product Likeliness | 2.249 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.013 |
| Pgp-sub | 0.002 |
| HIA | 0.002 |
| CACO-2 | -4.439 |
| MDCK | 0.0000198 |
| BBB | 0.979 |
| PPB | 0.87406 |
| VDSS | 4.496 |
| FU | 0.103983 |
| CYP1A2-inh | 0.968 |
| CYP1A2-sub | 0.14 |
| CYP2c19-inh | 0.711 |
| CYP2c19-sub | 0.714 |
| CYP2c9-inh | 0.318 |
| CYP2c9-sub | 0.498 |
| CYP2d6-inh | 0.216 |
| CYP2d6-sub | 0.226 |
| CYP3a4-inh | 0.237 |
| CYP3a4-sub | 0.274 |
| CL | 13.828 |
| T12 | 0.395 |
| hERG | 0.018 |
| Ames | 0.244 |
| ROA | 0.007 |
| SkinSen | 0.931 |
| Carcinogencity | 0.952 |
| EI | 0.847 |
| Respiratory | 0.032 |
| NR-Aromatase | 0.009 |
| Antiviral | No |
| Prediction | 0.680124 |